Authors
Loading...
Genome-wide CRISPR-Cas9 screen identifies TADA1's role in fetal hemoglobin and erythroid differentiation, suggesting new therapeutic targets for sickle cell anemia.
Huo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: